NCT06382012View on ClinicalTrials.gov

Antiemetic Fosaprepitant To Remedy Nausea and Vomiting

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

November 13, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Nausea and VomitingNauseaVomiting
Interventions
DRUG

Fosaprepitant 150 mg

Fosaprepitant 150mg IV administered over 15 minutes

DRUG

Ondansetron 4 mg

Ondansetron 4mg IV administered over 15 minutes

Trial Locations (1)

10467

RECRUITING

Montefiore Medical Center (Montefiore and Weiler EDs), The Bronx

All Listed Sponsors
lead

Montefiore Medical Center

OTHER